ArticleJournal of neuroinflammation2023

Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.

Tingting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.